DELFI DIAGNOSTICS, INC.

Profile

Company Names

DELFI DIAGNOSTICS, INC.

Addresses

1810 EMBARCADERO ROAD, SUITE 100, PALO ALTO, CA 94303

2809 BOSTON STREET, SUITE 503, BALTIMORE, MD 21224

301 W. 29TH STREET, BALTIMORE, MD 21211

1812 ASHLAND AVENUE, BALTIMORE, MD 21205

Phone Numbers

410-961-9015

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$365,923,520.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-12-01 
$34,333,315.00 
$60,000,000.00 
$25,666,685.00 
Debt 
4
2022-06-10 
$224,999,876.00 
$224,999,876.00 
$0.00 
Equity 
3
2021-01-12 
$101,074,986.00 
$101,074,986.00 
$0.00 
Equity 
2
2019-08-12 
$5,500,000.00 
$5,500,000.00 
$0.00 
Equity 
1
2018-06-18 
$15,343.00 
$15,343.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
 
BACH 
EXECUTIVE OFFICER
RIGHTCARE SOLUTIONS, INC.   |  ONCOLOGY ANALYTICS, INC.   |  DELFI DIAGNOSTICS, INC.
PETER 
B. 
BACH 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
JENNIFER 
 
BUECHEL 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
NICHOLAS 
 
DRACOPOLI 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
MICHAEL 
 
DYBBS 
DIRECTOR
VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SAMSARA BIOCAPITAL, L.P.   |  SUTRO BIOPHARMA INC   |  NKARTA, INC.   |  565 SPV I, L.P.   |  LEVO THERAPEUTICS, INC.   |  DELFI DIAGNOSTICS, INC.   |  ABCURO, INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
RISHI 
 
GUPTA 
DIRECTOR
GELESIS INC   |  SIENTRA, INC.   |  AVITIDE, INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  DIMENSION THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ATTENUA, INC.   |  TURNSTONE BIOLOGICS CORP.   |  GOLDEN TEAK CAPITAL L.P.   |  NEUROPACE INC   |  VERONA PHARMA PLC   |  CHARM THERAPEUTICS INC.   |  DELFI DIAGNOSTICS, INC.   |  AER THERAPEUTICS, INC.   |  HELICORE BIOVENTURES I, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
ELIZABETH 
 
HOMANS 
DIRECTOR
LYELL IMMUNOPHARMA, INC.   |  DELFI DIAGNOSTICS, INC.
JUSTIN 
 
KAO 
DIRECTOR
HELIX HOLDINGS I, LLC   |  INFLAMMATIX, INC.   |  EARLI INC.   |  DELFI DIAGNOSTICS, INC.
DOUGLAS 
 
SCHENKEL 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
AMOOLYA 
 
SINGH 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
LEE-ANN 
 
SMITH-FREEMAN 
EXECUTIVE OFFICER
DELFI DIAGNOSTICS, INC.
WILLIAM 
 
STEVENS 
EXECUTIVE OFFICER
PERSONAL GENOME DIAGNOSTICS INC.   |  SPECTRAL MEDICAL INC.   |  DELFI DIAGNOSTICS, INC.   |  CAPSULOMICS, INC.
WILLIAM 
J. 
STEVENS 
EXECUTIVE OFFICER
PERSONAL GENOME DIAGNOSTICS INC.   |  DELFI DIAGNOSTICS, INC.
SUSAN 
 
TOUSI 
EXECUTIVE OFFICER, DIRECTOR
DELFI DIAGNOSTICS, INC.
JACOB 
 
VAN NAARDEN 
DIRECTOR
DELFI DIAGNOSTICS, INC.
VICTOR 
 
VELCULESCU 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PERSONAL GENOME DIAGNOSTICS INC.   |  DELFI DIAGNOSTICS, INC.
GREG 
 
YAP 
DIRECTOR
CLEAR LABS, INC.   |  DELFI DIAGNOSTICS, INC.   |  PARTICLE HEALTH INC.   |  H1 INSIGHTS, INC.   |  VITAL LABS, INC.   |  OPHELIA HEALTH, INC.   |  RIVA HEALTH, INC.   |  KOALA HEALTH, INC.   |  CARTWHEEL CARE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-12-01 
2022-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-10 
2021-01-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-12 
2019-08-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-12 
2019-08-13
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
 
2018-06-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#